This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

NCT01676935 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
349
Enrollment
INDUSTRY
Sponsor class

Stopped Data obtained from the M11-427 study is not critical to the continued evaluation of ABT-126.

Conditions

Interventions

Sponsor

AbbVie (prior sponsor, Abbott)